Clinical effect on treatment of ARCO stage Ⅰ and Ⅱ femoral head necrosis with pivot channel needleknife
LIN Xueting1 YANG Peipei2 FU Weiyan1 NI Lixin1 ZHANG Yunyu1 ZHU Shanjia1 WANG Kailong2
1.Graduate School, Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530000, China;
2.Department of Rehabilitation Medicine, the First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi Zhuang Autonomous Region, Nanning 530000, China
Abstract：Objective To observe the clinical effect on treatment of ARCO stage Ⅰand Ⅱ ostecnecrosis of the femoral head (ONFH) with pivot channel needleknife. Methods A total of 60 patients with ONFH were selected from the Department of Rehabilitation Medicine, the First Affiliated Hospital of Guangxi University of Chinese Medicine from September 2019 to December 2020, and they were divided into treatment group and control group, with 30 patients in each group. The treatment group was treated with pivot channel needleknife combined with Osteoking, and the control group was treated with common acupuncture combined with Osteoking for three months, with a follow-up visit at the 12th month after the end of treatment. The outcome measures were Harris hip score (HHS), visual analogue scale (VAS) and quality of life scale (short form, SF-36). Results Shedding occurred in two patients in the treatment group; one case fell out in the control group and those cases were excluded, resulting in a final outcome analysis of 57 cases. The clinical effect of the treatment group was better than that of the control group, and the difference was statistically significant (P＜0.05). Comparison between groups, comparison at time point and interaction of VAS were statistically significant (P＜0.05). Further pair comparison and intra-group comparison: VAS scores of the two groups were lower after treatment and at follow-up than before treatment (P＜0.05); comparison between groups: after treatment and at follow-up, VAS score of the treatment group was lower than that of the control group, the differences were statistically significant (P＜0.05). There were significant differences in the total score of HHS, functional activities, and deformities among groups, time points and interaction (P＜0.05). The time point comparison and interaction differences of pain score were statistically significant (P＜0.05), but there was no statistical significance between groups (P＞0.05); the interaction of joint activcty score was statistically significant (P＜0.05). Further pairwise comparison and intra-group comparison: after treatment and at follow-up, the total score of HHS, pain, functional activity and joint activity scores of the two groups were higher than before treatment, the differences were statistically significant (P＜0.05), the deformity score of the treatment group was higher than before treatment (P＜0.05), the deformity score of the control group was not statistically significant before and after treatment (P＞0.05). Comparison between groups: after treatment and at follow-up, the total score of HHS, functional activities and malformation scores in the treatment group were higher than those in the control group, the differences were statistically significant (P＜0.05). The quality of life scores of the two groups were higher after treatment than before treatment, the differences were statistically significant (P＜0.05). After treatment, the scores of physiological function, physical pain, general health status, energy, social function, and mental health in the treatment group were higher than those in the control group, and the differences were statistically significant (treatment group). There was no significant difference in physiological function and emotional function scores between the two groups (P＞0.05). Conclusion It is effective to treat ONFH patients with ARCO stages Ⅰ and Ⅱwith pivot channel needleknife and common acupuncture, but the pivot channel needleknife is superior to the common acupuncture in the degree of improvement.
林雪婷1 杨培培2 符维艳1 倪李鑫1 张运玉1 朱珊葭1 王开龙2. 枢经针刀治疗ARCOⅠ、Ⅱ期股骨头坏死的临床效果[J]. 中国医药导报, 2023, 20(9): 144-149.
LIN Xueting1 YANG Peipei2 FU Weiyan1 NI Lixin1 ZHANG Yunyu1 ZHU Shanjia1 WANG Kailong2. Clinical effect on treatment of ARCO stage Ⅰ and Ⅱ femoral head necrosis with pivot channel needleknife. 中国医药导报, 2023, 20(9): 144-149.
京公网安备 11010502046598号